ArticlePloS one2018

17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.

Sandeep S Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.